FDA reports deaths with diabetes drug Byetta

The Food and Drug Administration said Monday it has received six new reports of patients developing a dangerous form of pancreatitis while taking Byetta. Two of the patients died and four were recovering.
Byetta competes against blockbuster drugs from GlaxoSmithKline PLC and Takeda Pharmaceuticals in the $24 billion global market for diabetes medications, according to health care research firm IMS Health.

Full Wire Service Article, SF Chronicle, August 18, 2008

________________________________

$24 billion for diabetes drugs, virtually all of which have side effects that can lead to death. And we're to believe that the pharmaceutical drug cartel, American Diabetes Association, etc., are looking for a cure?

If you believe that, have I got a heck of a deal on a bridge for you...

TLC